aminolevulinic acid has been researched along with Bile Duct Cancer in 9 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hexyl-aminolevulinic acid (HALA) was compared with aminolevulinic acid (ALA) in terms of improving ALA-based photodynamic therapy (PDT) for human intra- and extrahepatic cholangiocarcinoma (CCA) HuCC-T1 and SNU1196 cells." | 7.79 | Aminolevulinic acid derivatives-based photodynamic therapy in human intra- and extrahepatic cholangiocarcinoma cells. ( Chung, CW; Chung, KD; Jeong, YI; Kang, DH; Kim, CH; Kim, DH; Kwak, TW; Lee, HM, 2013) |
| "Celecoxib is an anti-inflammatory drug that induces intracellular ROS generation." | 5.39 | Synergistic effects of 5-aminolevulinic acid based photodynamic therapy and celecoxib via oxidative stress in human cholangiocarcinoma cells. ( Chung, CW; Jeong, YI; Kang, DH; Kim, CH; Kim, DH; Kwak, TW; Lee, HM, 2013) |
| "Four patients with nonresectable bile duct cancer underwent cholangiography, cholangioscopy, and intraductal US before PDT." | 5.31 | Photodynamic therapy with 5-aminolevulinic acid is not effective in bile duct cancer. ( Apel, D; Arnold, JC; Jakobs, R; Riemann, JF; Rosenbaum, A; Zoepf, T, 2001) |
| "Hexyl-aminolevulinic acid (HALA) was compared with aminolevulinic acid (ALA) in terms of improving ALA-based photodynamic therapy (PDT) for human intra- and extrahepatic cholangiocarcinoma (CCA) HuCC-T1 and SNU1196 cells." | 3.79 | Aminolevulinic acid derivatives-based photodynamic therapy in human intra- and extrahepatic cholangiocarcinoma cells. ( Chung, CW; Chung, KD; Jeong, YI; Kang, DH; Kim, CH; Kim, DH; Kwak, TW; Lee, HM, 2013) |
| "Although curability for extrahepatic cholangiocarcinoma is expected with surgery alone, patients with unresectable or remnant biliary cancer need other effective palliative therapies, including PDT." | 2.72 | Recent Advances in Photodynamic Imaging and Therapy in Hepatobiliary Malignancies: Clinical and Experimental Aspects. ( Hamada, T; Hiyoshi, M; Imamura, N; Kai, K; Nanashima, A; Yano, K, 2021) |
| "Celecoxib is an anti-inflammatory drug that induces intracellular ROS generation." | 1.39 | Synergistic effects of 5-aminolevulinic acid based photodynamic therapy and celecoxib via oxidative stress in human cholangiocarcinoma cells. ( Chung, CW; Jeong, YI; Kang, DH; Kim, CH; Kim, DH; Kwak, TW; Lee, HM, 2013) |
| "Four patients with nonresectable bile duct cancer underwent cholangiography, cholangioscopy, and intraductal US before PDT." | 1.31 | Photodynamic therapy with 5-aminolevulinic acid is not effective in bile duct cancer. ( Apel, D; Arnold, JC; Jakobs, R; Riemann, JF; Rosenbaum, A; Zoepf, T, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Nanashima, A | 1 |
| Hiyoshi, M | 1 |
| Imamura, N | 1 |
| Yano, K | 1 |
| Hamada, T | 1 |
| Kai, K | 1 |
| Hirao, M | 1 |
| Hosui, A | 1 |
| Mimura, A | 1 |
| Ohnishi, K | 1 |
| Tanimoto, T | 1 |
| Okahara, T | 1 |
| Sueyoshi, Y | 1 |
| Goto, T | 1 |
| Yamada, T | 1 |
| Hiramatsu, N | 1 |
| Chung, CW | 4 |
| Kim, CH | 3 |
| Lee, HM | 2 |
| Kim, DH | 3 |
| Kwak, TW | 2 |
| Chung, KD | 2 |
| Jeong, YI | 4 |
| Kang, DH | 4 |
| Choi, KH | 1 |
| Yoo, JJ | 2 |
| Kim, C | 1 |
| Nishioka, NS | 1 |
| Zoepf, T | 1 |
| Jakobs, R | 1 |
| Rosenbaum, A | 1 |
| Apel, D | 1 |
| Arnold, JC | 1 |
| Riemann, JF | 1 |
| Fujiwara, H | 1 |
| Takahara, N | 1 |
| Tateishi, K | 1 |
| Tanaka, M | 1 |
| Kanai, S | 1 |
| Kato, H | 1 |
| Nakatsuka, T | 1 |
| Yamamoto, K | 1 |
| Kogure, H | 1 |
| Arita, J | 1 |
| Nakai, Y | 1 |
| Kasuga, M | 1 |
| Ushiku, T | 1 |
| Hasegawa, K | 1 |
| Koike, K | 1 |
1 review available for aminolevulinic acid and Bile Duct Cancer
| Article | Year |
|---|---|
Recent Advances in Photodynamic Imaging and Therapy in Hepatobiliary Malignancies: Clinical and Experimental Aspects.
Topics: Aminolevulinic Acid; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Humans; Phot | 2021 |
8 other studies available for aminolevulinic acid and Bile Duct Cancer
| Article | Year |
|---|---|
Significance of in vitro photodynamic cytodiagnosis with 5-aminolevulinic acid in biliary brush cytology for malignant biliary stricture.
Topics: Aminolevulinic Acid; Bile Duct Neoplasms; Cholestasis; Constriction, Pathologic; Cytodiagnosis; Huma | 2022 |
Aminolevulinic acid derivatives-based photodynamic therapy in human intra- and extrahepatic cholangiocarcinoma cells.
Topics: Aminolevulinic Acid; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cholangiocarci | 2013 |
Synergistic effects of 5-aminolevulinic acid based photodynamic therapy and celecoxib via oxidative stress in human cholangiocarcinoma cells.
Topics: Aminolevulinic Acid; Analysis of Variance; Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; C | 2013 |
Effect of surfactant on 5-aminolevulinic acid uptake and PpIX generation in human cholangiocarcinoma cell.
Topics: Aminolevulinic Acid; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Survival; | 2012 |
5-aminolevulinic acid-incorporated poly(vinyl alcohol) nanofiber-coated metal stent for application in photodynamic therapy.
Topics: Aminolevulinic Acid; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Survival; | 2012 |
Drug, light, and oxygen: a dynamic combination in the clinic.
Topics: Aminolevulinic Acid; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Esophageal N | 1998 |
Photodynamic therapy with 5-aminolevulinic acid is not effective in bile duct cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Aminolevulinic Acid; Bile Duct Neoplasms; Cholangiogr | 2001 |
5-Aminolevulinic acid-mediated photodynamic activity in patient-derived cholangiocarcinoma organoids.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Animals; Bile Duct Neoplasms; Cholangiocarcinoma; Fema | 2020 |